• Amerinet (St. Louis) reported appointments in its sales and contracting divisions. Joining the sales division are Allie Karshenas, PhD, as eastern area VP of sales, and Robynn Sweet, as director of business development. New to the contracting division is Steven Jenks, as VP of custom contracting, while Dale Wright has been promoted to the position of senior VP of contracting services and president of Amerinet Choice. Karshenas was previously VP of operations at Thermo Fisher Scientific. Sweet was a strategic account manager for Becton Dickinson. Jenks' previous industry experience includes work in GPO management, executive sales and management, and supply cost management. Jenks was promoted from VP for Amerinet Choice, Amerinet's own private label product line. Amerinet offers what it calls Total Spend Management Solutions to assist healthcare providers to improve operating margins.

• Direct Flow Medical (Santa Rosa, California) has named Paul LaViolette to the company's board. LaViolette is a senior advisor at Boston Scientific. Direct Flow makes minimally invasive implants to treat heart valve disease.

• Dr. David Ginsberg has been named CEO of Encorium Group (Wayne, Pennsylvania). Ginsberg assumes the position from Dr. Kai Lindevall, who was named to the newly created position of executive chairman. Most recently, Ginsberg was the VP of medical affairs and clinical affairs for KV Pharmaceuticals. The company also named David Morra to its board. Morra is a managing director of Union Partners. Encoruim is a multinational clinical research organization.

• Michael Dicke has been named associate regional director for enforcement in the San Francisco Regional Office of the U.S. Securities & Exchange Commission. Dicke joined the SEC in 1996 as a staff attorney after five years in private practice. Most recently, Dicke was an assistant regional director for enforcement.